BamSEC and AlphaSense Join Forces
Learn More

Medicis Pharmaceutical Corp

Formerly NYSE: MRX

Material Contracts Filter

EX-10.2
from 10-Q 3 pages Amendment to Stock Purchase Agreement
12/34/56
EX-10.1
from DEFA14A 7 pages Settlement Agreement
12/34/56
EX-10.1
from 8-K 7 pages Settlement Agreement
12/34/56
EX-10.8
from 8-K 27 pages Additional Warrant Transaction Confirmation, Dated as of May 11, 2012
12/34/56
EX-10.7
from 8-K 28 pages Deutsche Bank AG Is Not Registered as a Broker or Dealer Under the U.S. Securities Exchange Act of 1934, as Amended. Deutsche Bank Securities Inc. (“Agent”) Has Acted Solely as Agent in Connection With the Transaction and Has No Obligation, by Way of Issuance, Endorsement, Guarantee or Otherwise With Respect to the Performance of Either Party Under the Transaction. as Such, All Delivery of Funds, Assets, Notices, Demands and Communications of Any Kind Relating to the Transaction Between Deutsche Bank AG and Counterparty Shall Be Transmitted Exclusively Through Agent. Deutsche Bank AG, London Branch Is Not a Member of the Securities Investor Protection Corporation (Sipc)
12/34/56
EX-10.6
from 8-K 24 pages Additional Note Hedge Transaction Confirmation, Dated as of May 11, 2012
12/34/56
EX-10.5
from 8-K 24 pages Deutsche Bank AG Is Not Registered as a Broker or Dealer Under the U.S. Securities Exchange Act of 1934, as Amended. Deutsche Bank Securities Inc. (“Agent”) Has Acted Solely as Agent in Connection With the Transaction and Has No Obligation, by Way of Issuance, Endorsement, Guarantee or Otherwise With Respect to the Performance of Either Party Under the Transaction. as Such, All Delivery of Funds, Assets, Notices, Demands and Communications of Any Kind Relating to the Transaction Between Deutsche Bank AG and Counterparty Shall Be Transmitted Exclusively Through Agent. Deutsche Bank AG, London Branch Is Not a Member of the Securities Investor Protection Corporation (Sipc)
12/34/56
EX-10.4
from 8-K 27 pages Base Warrant Transaction Confirmation, Dated as of May 10, 2012
12/34/56
EX-10.3
from 8-K 28 pages Deutsche Bank AG Is Not Registered as a Broker or Dealer Under the U.S. Securities Exchange Act of 1934, as Amended. Deutsche Bank Securities Inc. (“Agent”) Has Acted Solely as Agent in Connection With the Transaction and Has No Obligation, by Way of Issuance, Endorsement, Guarantee or Otherwise With Respect to the Performance of Either Party Under the Transaction. as Such, All Delivery of Funds, Assets, Notices, Demands and Communications of Any Kind Relating to the Transaction Between Deutsche Bank AG and Counterparty Shall Be Transmitted Exclusively Through Agent. Deutsche Bank AG, London Branch Is Not a Member of the Securities Investor Protection Corporation (Sipc)
12/34/56
EX-10.2
from 8-K 24 pages Base Note Hedge Transaction Confirmation, Dated as of May 10, 2012
12/34/56
EX-10.1
from 8-K 24 pages Deutsche Bank AG Is Not Registered as a Broker or Dealer Under the U.S. Securities Exchange Act of 1934, as Amended. Deutsche Bank Securities Inc. (“Agent”) Has Acted Solely as Agent in Connection With the Transaction and Has No Obligation, by Way of Issuance, Endorsement, Guarantee or Otherwise With Respect to the Performance of Either Party Under the Transaction. as Such, All Delivery of Funds, Assets, Notices, Demands and Communications of Any Kind Relating to the Transaction Between Deutsche Bank AG and Counterparty Shall Be Transmitted Exclusively Through Agent. Deutsche Bank AG, London Branch Is Not a Member of the Securities Investor Protection Corporation (Sipc)
12/34/56
EX-10.3
from 10-Q 107 pages Amended and Restated Collaboration Agreement by and Between Ucyclyd Pharma, Inc. and Hyperion Therapeutics, Inc. Dated March 22, 2012
12/34/56
EX-10.2
from 10-Q 2 pages Pursuant to the Agreement, Medicis Was Granted Rights With Respect to the Current Product in the Territory, Which Includes Japan. Without Affecting the Remaining Rights and Obligations of the Parties Under the Agreement, by Signing This Letter, Ipsen and Medicis Hereby Agree to Terminate Medicis’ Right to Distribute the Current Product in Japan Effective as of the Date of This Letter. Such Termination Is Without Liability to Either Party Resulting From Such Termination. if You Agree With the Foregoing, Please Sign and Return to Me a Fully Executed Copy of This Letter. Please Do Not Hesitate to Contact Me Should You Have Any Questions. Sincerely, Medicis Pharmaceutical Corporation By: /S/ Mark A. Prygocki, Sr. Mark A. Prygocki, Sr. President
12/34/56
EX-10.1
from 10-Q 3 pages Amendment No. 1 to License and Settlement Agreement
12/34/56
EX-10.1
from 8-K 62 pages Asset Purchase Agreement Dated as of November 18, 2011 by and Between Medicis Pharmaceutical Corporation and Graceway Pharmaceuticals, LLC and the Other Parties Signatory Hereto
12/34/56
EX-10.5
from 10-Q 3 pages Amendment No. 1 to the Medicis Pharmaceutical Corporation Supplemental Executive Retirement Plan
12/34/56
EX-10.4
from 10-Q 103 pages Stock Purchase Agreement by and Between Medicis Pharmaceutical Corporation (“Seller”) and Solta Medical, Inc. (“Buyer”) Dated as of September 12, 2011
12/34/56
EX-10.3
from 10-Q 24 pages License and Settlement Agreement
12/34/56
EX-10.2
from 10-Q 26 pages License and Settlement Agreement
12/34/56
EX-10.1
from 10-Q 23 pages License and Settlement Agreement
12/34/56